Results 1 to 10 of about 17,467 (192)

Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride

open access: yesIndian Dermatology Online Journal, 2015
Background: Finasteride acts by reducing dihydrotestosterone levels, thereby inhibiting miniaturization of hair follicles in patients with androgenetic alopecia (AGA).
B S Chandrashekar   +4 more
doaj   +2 more sources

Altered Skin Permeation of Finasteride Using Clove Oil, Urea, and Lyophilized Powder of Grape Seed Extract [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2023
Purpose: Finasteride is a 5-alpha reductase inhibitor used to treat hair loss and acne. The skin permeation of finasteride is one of the main challenges associated with dermal drug delivery.
Anayatollah Salimi   +2 more
doaj   +3 more sources

Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date

open access: yesDrug Design, Development and Therapy, 2020
Wimolsiri Iamsumang, Kanchana Leerunyakul, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Poonkiat Suchonwanit Email poonkiat@hotmail ...
Poonkiat Suchonwanit   +2 more
exaly   +2 more sources

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial. [PDF]

open access: yesPLoS ONE, 2015
OBJECTIVE:In the Prostate Cancer Prevention Trial (PCPT), finasteride reduced the risk of prostate cancer by 25%, even though high-grade prostate cancer was more common in the finasteride group.
Cindy H Chau   +15 more
doaj   +1 more source

Resistance Training Ameliorates Finasteride-Induced Disturbance in Protein Homeostasis in Skeletal Muscle of Rats [PDF]

open access: yes운동과학, 2019
PURPOSE Finasteride is a competitive inhibitor of 5-alpha reductase type 2 enzyme that is commonly used to treat benign prostatic hyperplasia and male pattern hair loss. It is not clear about the synergistic effects of finasteride and resistance training
Sung-hee Oh   +3 more
doaj   +1 more source

Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules

open access: yesBMC Chemistry, 2022
Entadfi™ is a recently FDA approved pharmaceutical combination capsule of finasteride and tadalafil. It was prescribed for the treatment of urinary tract disorders caused by benign prostatic hyperplasia in men.
Ahmed H. Abdelazim, Sherif Ramzy
doaj   +1 more source

The intriguing role of fibroblasts and c-Jun in the chemopreventive and therapeutic effect of finasteride on xenograft models of prostate cancer

open access: yesAsian Journal of Andrology, 2016
In a large clinical trial, finasteride reduced the rate of low-grade prostate cancer (PCa) while increasing the incidence of high-grade cancer. Whether finasteride promotes the development of high-grade tumors remains controversial.
Yi-Nong Niu   +6 more
doaj   +1 more source

Influence of Postoperative Finasteride Therapy on Recurrence of Gynecomastia After Mastectomy in Men Taking Finasteride for Alopecia

open access: yesAmerican Journal of Men's Health, 2019
Finasteride is commonly used for treatment of alopecia. Because finasteride is a cause of gynecomastia, there is concern regarding the continuation of finasteride therapy after mastectomy.
Seung Geun Lee MD, PhD   +9 more
doaj   +1 more source

Does treatment with dutasteride or finasteride has impact on renal morphology? Experimental study

open access: yesActa Cirúrgica Brasileira, 2021
Purpose: To investigate whether renal modifications occur following treatment with dutasteride or finasteride. Methods: Twenty-four male rats were divided into three groups: control (that received distilled water), dutasteride (0.5 mg/kg/day), and ...
Marcello Henrique Araújo da Silva   +4 more
doaj   +1 more source

The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia

open access: yesBMC Urology, 2002
Background Finasteride, a 5 alpha reductase inhibitor, is an established treatment for benign prostatic hyperplasia. The recommended dosage is 5 mg a day, however case reports have show effectiveness with lower doses.
Geller Jack, Sullivan Michael J
doaj   +1 more source

Home - About - Disclaimer - Privacy